Literature DB >> 33398838

Current Topics of Optogenetics for Medical Applications Toward Therapy.

Toshihiro Kushibiki1.   

Abstract

The optogenetics approach uses a combination of genetic and optical methods to initiate and control functions in specific cells of biological tissues. Since the high-speed control of neuronal activity by irradiating channelrhodopsin-2 with blue light was reported in 2005, tremendous advancement and application of optogenetics in the field of neuroscience, such as in studies that associate neuronal activity with behaviors, have been initiated. Optogenetics is not only used as a research tool, but is also started to apply in the diagnosis of a disease or as therapy in various studies. Here, I summarize current reports on therapy using a typical photopigment used in optogenetics, channelrhodopsin-2.

Entities:  

Keywords:  Cardiac resynchronization; Channnelrhodopsin-2; Diabetes; Gene therapy; Insulin; Neuroscience; Optogenetics

Year:  2021        PMID: 33398838     DOI: 10.1007/978-981-15-8763-4_35

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  56 in total

1.  Millisecond-timescale, genetically targeted optical control of neural activity.

Authors:  Edward S Boyden; Feng Zhang; Ernst Bamberg; Georg Nagel; Karl Deisseroth
Journal:  Nat Neurosci       Date:  2005-08-14       Impact factor: 24.884

2.  Temporally precise in vivo control of intracellular signalling.

Authors:  Raag D Airan; Kimberly R Thompson; Lief E Fenno; Hannah Bernstein; Karl Deisseroth
Journal:  Nature       Date:  2009-03-18       Impact factor: 49.962

Review 3.  Optogenetic stimulation of serotonin nuclei retrieve the lost memory in Alzheimer's disease.

Authors:  Mehmet Bostancıklıoğlu
Journal:  J Cell Physiol       Date:  2019-07-22       Impact factor: 6.384

Review 4.  Toward the Optical Cochlear Implant.

Authors:  Tobias Dombrowski; Vladan Rankovic; Tobias Moser
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

5.  Spatiotemporal control of gene expression in mammalian cells and in mice using the LightOn system.

Authors:  Xianjun Chen; Xue Wang; Zengmin Du; Zhengcai Ma; Yi Yang
Journal:  Curr Protoc Chem Biol       Date:  2013

6.  Optogenetic neuronal stimulation promotes functional recovery after stroke.

Authors:  Michelle Y Cheng; Eric H Wang; Wyatt J Woodson; Stephanie Wang; Guohua Sun; Alex G Lee; Ahmet Arac; Lief E Fenno; Karl Deisseroth; Gary K Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

7.  Illuminating Parkinson's therapy with optogenetics.

Authors:  Yuejun Chen; Man Xiong; Su-Chun Zhang
Journal:  Nat Biotechnol       Date:  2015-02       Impact factor: 54.908

8.  Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes.

Authors:  Brian O Bingen; Marc C Engels; Martin J Schalij; Wanchana Jangsangthong; Zeinab Neshati; Iolanda Feola; Dirk L Ypey; Saïd F A Askar; Alexander V Panfilov; Daniël A Pijnappels; Antoine A F de Vries
Journal:  Cardiovasc Res       Date:  2014-07-31       Impact factor: 10.787

9.  Optogenetics.

Authors:  Karl Deisseroth
Journal:  Nat Methods       Date:  2010-12-20       Impact factor: 28.547

10.  Optical control of muscle function by transplantation of stem cell-derived motor neurons in mice.

Authors:  J Barney Bryson; Carolina Barcellos Machado; Martin Crossley; Danielle Stevenson; Virginie Bros-Facer; Juan Burrone; Linda Greensmith; Ivo Lieberam
Journal:  Science       Date:  2014-04-04       Impact factor: 47.728

View more
  1 in total

Review 1.  Current approaches to characterize micro- and macroscale circuit mechanisms of Parkinson's disease in rodent models.

Authors:  Yangfan Peng; Nina Schöneberg; Maria Soledad Esposito; Jörg R P Geiger; Andrew Sharott; Philip Tovote
Journal:  Exp Neurol       Date:  2022-02-09       Impact factor: 5.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.